Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of two basal insulin analogs (insulin lispro protamine suspension and insulin determir) in basal-bolus therapy for patients with type 1 diabetes.

Trial Profile

Comparison of two basal insulin analogs (insulin lispro protamine suspension and insulin determir) in basal-bolus therapy for patients with type 1 diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Insulin detemir; Insulin neutral protamine lispro/insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 25 Sep 2008 The actual number of patients enrolled was 388 according to ClinicalTrials.gov record.
    • 25 Sep 2008 Status changed from active, no longer recruiting to completed as reported in the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top